EyeScreen™ Human+AI Diagnostic Service to be launched at ATA 2019

Combining the high accuracy of AI disease detection with the accepted practice of human grading, the EyeScreen™ Service for diabetic retinopathy (DR) identifies cases of referable DR in any clinical

EyeScreen™ Human+AI Diagnostic Service to be launched at ATA 2019 Read More »